Ependymoma

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma

Rare CNS Tumors Outcomes &Risk

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

B7-H3.CD28Z.CART in CNS Neoplasms

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Social Determinants of Health in Glioblastoma Population

AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors

Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)

Selumetinib for NF2-Related Schwannomatosis

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

Methionine PET/CT Studies In Patients With Cancer

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).